Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes

Atherosclerosis

Volumn 212, Issue 1, 2010, Pages 243-245

  Nakatsuji, Hideaki ^a   Kishida, Ken ^a   Funahashi, Tohru ^a   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adiponectin; FatROS; ROS; Thiazolidinediones

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOREACTIVE INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PIOGLITAZONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ADULT; AGED; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; JAPANESE; LETTER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; JAPAN; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; THIAZOLIDINEDIONES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS; TREATMENT OUTCOME;

EID: 77956232381     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.05.025     Document Type: Letter

References (16)

1. Roper N.A., Bilous R.W., Kelly W.F., Unwin N.C., Connolly V.M. Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ 2001, 322:1389-1393.
2. Dormandy J.A., Charbonnel B., Eckland D.J., et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 2005, 366:1279-1289.
3. Maeda N., Takahashi M., Funahashi T., et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001, 50:2094-2099.
4. Iwaki M., Matsuda M., Maeda N., et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003, 52:1655-1663.
5. Staels B. PPARgamma and atherosclerosis. Curr Med Res Opin 2005, 21(Suppl. 1):S13-20.
6. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54:1615-1625.
7. Furukawa S., Fujita T., Shimabukuro M., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004, 114:1752-1761.
8. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
9. Okuno Y., Matsuda M., Kobayashi H., et al. Adipose expression of catalase is regulated via a novel remote PPARgamma-responsive region. Biochem Biophys Res Commun 2008, 366:698-704.
10. Dobrian A.D., Schriver S.D., Khraibi A.A., Prewitt R.L. Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity. Hypertension 2004, 43:48-56.
11. Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity New criteria for 'obesity disease' in Japan. Circ J 2002, 66:987-992.
12. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976, 15:212-216.
13. Fujita K., Nishizawa H., Funahashi T., Shimomura I., Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 2006, 70:1437-1442.
14. Okuno Y., Matsuda M., Miyata Y., et al. Human catalase gene is regulated by peroxisome proliferator activated receptor-gamma through a response element distinct from that of mouse. Endocr J 2010, 57:303-309.
15. Fujita K., Maeda N., Sonoda M., et al. Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha. Arterioscler Thromb Vasc Biol 2008, 28:863-870.
16. Ohashi K., Iwatani H., Kihara S., et al. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler Thromb Vasc Biol 2007, 27:1910-1917.